Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) has made its fourth quarter fiscal 2022 financial results available online, following the period ending April 2, 2022. A conference call will be held on May 10, 2022, at 8:00 a.m. EDT to discuss these results. Investors can access the earnings release, analytical tables, and supplemental information on the Investor Relations website. The earnings call will also be available for replay for one year after the event.

Financial release accessible online

BOSTON, May 10, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2022, which ended April 2, 2022, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. EDT on May 10, 2022. The conference call and webcast can be accessed with the following information:

• U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
• Conference ID required for access: 5347317
• A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/gooqch6s

In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.  

Direct link to 4Q FY22 Earnings Release:
https://haemonetics.gcs-web.com/static-files/864cad71-8258-4574-a33e-beaddcb84f33

Direct link to 4Q FY22 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/52e9f8bf-c0fc-490a-af79-5fe4fef86e06

A replay of the conference call and webcast will be available for one year beginning on May 10, 2022, at 11:00 a.m. EDT using the conference call webcast link provided in this press release.

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olgaguyette@haemoneticscom	davidtrenk@haemoneticscom
Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemoneticscom

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-4th-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website-301543450.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics report its fourth quarter fiscal 2022 earnings?

Haemonetics will report its fourth quarter fiscal 2022 earnings on May 10, 2022.

What time is the Haemonetics earnings conference call?

The earnings conference call is scheduled for 8:00 a.m. EDT on May 10, 2022.

Where can I find Haemonetics' fourth quarter fiscal 2022 financial results?

The financial results are available on Haemonetics' Investor Relations website.

Will there be a replay of the Haemonetics earnings call?

Yes, a replay of the earnings call will be available for one year starting from May 10, 2022.